Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

LCAHA

Cat. No.: IBDI-432265

LCAHA (LCA hydroxyamide) is a deubiquitinase USP2a inhibitor with IC50s of 9.7 μM and 3.7μM in Ub-AMC Assay and Di-Ub Assay, respectively. LCAHA destabilizes Cyclin D1 and induces G0/G1 arrest by inhibiting deubiquitinase USP2a.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target Deubiquitinase
Molecular Weight 391.59
Appearance Solid
Synonyms LCA hydroxyamide
SMILES C[[email protected]@]12[[email protected]](CC[[email protected]]2([H])[[email protected]](C)CCC(NO)=O)([H])[[email protected]@]3([H])[[email protected]@](CC1)([H])[[email protected]@]4([[email protected]](C[[email protected]@H](CC4)O)([H])CC3)C
Purity 98.05%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C/3 years; 4°C/2 years
In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.